Shire to pay $56.5 million to settle improper marketing probe

September 24, 2014 7:01 PM

3 0

Shire to pay $56.5 million to settle improper marketing probe

(Reuters) - Shire Plc, which is in the process of being acquired by AbbVie Inc, has agreed to pay $56.5 million to resolve allegations of making false claims in the marketing of its ADHD drug Adderall XR, the U.S. Justice Department said on Wednesday.

The settlement involved charges that Ireland-based Shire, between January 2004 and December 2007, promoted its extended release Adderall with claims of superiority over rival medicines that were not supported by clinical data, the Justice Department said.

Read more

To category page

Loading...